Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03802981 · ClinicalTrials.gov registry record
A Registry for Patients With Multifocal Ground Glass Opacities (GGOs)
A clinical trial of Multiple Ground Glass Opacities (GGOs), sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- 338
- Enrollment target
- 20
- Study locations
NCT03802981 is a study of Multiple Ground Glass Opacities (GGOs) that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 338 participants. The trial reports 20 study locations across 10 states.
The verdict
NCT03802981, a study of Multiple Ground Glass Opacities (GGOs), is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 338 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this registry study is to actively monitor people with GGOs and collect information about them, so that investigators can learn more about these lesions and about the risk of developing lung cancer in study participants whose GGOs are being monitored in the active surveillance program.
Conditions Studied
Study Locations (20)
New York
- Roswell Park Cancer Institute (Data Collection Only) - Buffalo
- Memorial Sloan Kettering Commack - Commack
- Memorial Sloan Kettering Westchester - Harrison
- Memorial Sloan Kettering Cancer Center - New York
- New York Presbyterian Hospital - New York
- Memorial Sloan Kettering Nassau - Uniondale
New Jersey
- Memorial Sloan Kettering Basking Ridge - Basking Ridge
- Memorial Sloan Kettering Monmouth - Middletown
- Memorial Sloan Kettering Bergen - Montvale
California
- University of California San Diego - San Diego
- Stanford University Medical Center (Data collection only) - Stanford
Massachusetts
- Massachusetts General Hospital Cancer Center - Boston
- Brigham and Women's Hospital - Boston
Missouri
- George Washington University School of Medicine - St Louis
- Washington University School of Medicine - St Louis
Connecticut
- Hartford Healthcare - Hartford
Illinois
- Rush University Medical Center (Data collection only) - Chicago
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 338 participants |
| Start Date | 2019-01-09 |
| Est. Completion | 2027-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03802981
The ClinicalTrials.gov registry entry for NCT03802981 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 338 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Multiple Ground Glass Opacities (GGOs) appearing as the primary indexed condition, and to 0 interventions.
NCT03802981 reports 20 study locations spanning 10 distinct geographic areas - top geographies include New York, New Jersey, California.
Frequently Asked Questions
What is clinical trial NCT03802981 about?
NCT03802981 is a clinical study titled "A Registry for Patients With Multifocal Ground Glass Opacities (GGOs)". The purpose of this registry study is to actively monitor people with GGOs and collect information about them, so that investigators can learn more about these lesions and about the risk of developing lung cancer in study participants whose GGOs are being monitored in the active surveillance program...
What is the current status of trial NCT03802981?
This trial is currently active not recruiting. The enrollment target is 338 participants. The study started on 2019-01-09. Estimated completion is 2027-01.
What conditions does trial NCT03802981 study?
This clinical trial studies the following conditions: Multiple Ground Glass Opacities (GGOs).
Who is sponsoring clinical trial NCT03802981?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03802981 being conducted?
This trial has 20 study locations across California, Connecticut, Illinois, Massachusetts, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.